Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

This program funds investigator-initiated research on how bariatric surgery affects cancer risk, including animal studies, human studies, or both. It is for new, resubmission, and revision applications that do not propose clinical trials. Eligible applicants include a wide range of U.S. institutions and organizations, including nonprofits, for-profits, governments, tribal entities, and foreign organizations are not eligible to apply. The combined direct-cost budget for the two-year project period may not exceed $275,000, with no more than $200,000 in any single year, and no cost sharing is required. Applications should focus on the bariatric surgery procedures now commonly used, especially sleeve gastrectomy and Roux-en-Y gastric bypass, and foreign components are allowed.

✳ AI-generated summary — verify against the announcement

• Education
• Health
• Research & Discovery
• Researchers & Scholars
• Biomedical & Disease Research

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments